These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 36982717)

  • 1. Markers of Iron Metabolism and Outcomes in Patients with Heart Failure: A Systematic Review.
    Dhaliwal S; Kalogeropoulos AP
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality.
    Sierpinski R; Josiak K; Suchocki T; Wojtas-Polc K; Mazur G; Butrym A; Rozentryt P; van der Meer P; Comin-Colet J; von Haehling S; Kosmala W; Przewlocka-Kosmala M; Banasiak W; Nowak J; Voors AA; Anker SD; Cleland JGF; Ponikowski P; Jankowska EA
    Eur J Heart Fail; 2021 Jun; 23(6):919-932. PubMed ID: 33111457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron status in patients with chronic heart failure.
    Jankowska EA; Malyszko J; Ardehali H; Koc-Zorawska E; Banasiak W; von Haehling S; Macdougall IC; Weiss G; McMurray JJ; Anker SD; Gheorghiade M; Ponikowski P
    Eur Heart J; 2013 Mar; 34(11):827-34. PubMed ID: 23178646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Criteria for Iron Deficiency in Patients With Heart Failure.
    Masini G; Graham FJ; Pellicori P; Cleland JGF; Cuthbert JJ; Kazmi S; Inciardi RM; Clark AL
    J Am Coll Cardiol; 2022 Feb; 79(4):341-351. PubMed ID: 35086656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients With Heart Failure: Results From the DEFINE-HF and BIOSTAT-CHF Studies.
    Grote Beverborg N; van der Wal HH; Klip IT; Anker SD; Cleland J; Dickstein K; van Veldhuisen DJ; Voors AA; van der Meer P
    JAMA Cardiol; 2019 Jul; 4(7):696-701. PubMed ID: 31188392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF.
    Docherty KF; Welsh P; Verma S; De Boer RA; O'Meara E; Bengtsson O; Køber L; Kosiborod MN; Hammarstedt A; Langkilde AM; Lindholm D; Little DJ; Sjöstrand M; Martinez FA; Ponikowski P; Sabatine MS; Morrow DA; Schou M; Solomon SD; Sattar N; Jhund PS; McMurray JJV;
    Circulation; 2022 Sep; 146(13):980-994. PubMed ID: 35971840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients.
    Grote Beverborg N; Klip IT; Meijers WC; Voors AA; Vegter EL; van der Wal HH; Swinkels DW; van Pelt J; Mulder AB; Bulstra SK; Vellenga E; Mariani MA; de Boer RA; van Veldhuisen DJ; van der Meer P
    Circ Heart Fail; 2018 Feb; 11(2):e004519. PubMed ID: 29382661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron deficiency and short-term adverse events in patients with decompensated heart failure.
    Palau P; Llàcer P; Domínguez E; Tormo JP; Zakarne R; Mollar A; Martínez A; Miñana G; Santas E; Almenar L; Fácila L; De La Espriella R; Núñez E; Manzano L; Bayés-Genís A; Núñez J
    Clin Res Cardiol; 2021 Aug; 110(8):1292-1298. PubMed ID: 33721056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron deficiency is an independent risk factor of increased myocardial energy expenditure in chronic heart failure patients.
    Lin F; Huang Y; An D; Zhan Q; Wang P; Lai W; Zeng Q; Dong S; Ren H; Xu D
    Ann Palliat Med; 2021 Dec; 10(12):12061-12071. PubMed ID: 35016401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.
    Bekfani T; Pellicori P; Morris D; Ebner N; Valentova M; Sandek A; Doehner W; Cleland JG; Lainscak M; Schulze PC; Anker SD; von Haehling S
    Clin Res Cardiol; 2019 Feb; 108(2):203-211. PubMed ID: 30051186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to diagnose iron deficiency in chronic disease: A review of current methods and potential marker for the outcome.
    Rohr M; Brandenburg V; Brunner-La Rocca HP
    Eur J Med Res; 2023 Jan; 28(1):15. PubMed ID: 36617559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum iron level and physical function in heart failure patients is lost by presence of diabetes.
    Ohori K; Yano T; Katano S; Nagaoka R; Numazawa R; Yamano K; Fujisawa Y; Kouzu H; Nagano N; Fujito T; Nishikawa R; Ohwada W; Sato T; Furuhashi M
    ESC Heart Fail; 2024 Feb; 11(1):513-523. PubMed ID: 38088258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure.
    Graham FJ; Pellicori P; Masini G; Cuthbert JJ; Clark AL; Cleland JGF
    ESC Heart Fail; 2023 Oct; 10(5):2826-2836. PubMed ID: 37400990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Soluble Transferrin Receptor and Clinical Outcomes in Patients With Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE Study.
    Fitzsimons S; Poppe KK; Choi Y; Devlin G; Lund M; Lam CSP; Troughton R; Richards AM; Doughty RN
    J Card Fail; 2022 Aug; 28(8):1255-1263. PubMed ID: 35051624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of Iron Availability and Demand in Patients With Acute and Chronic Heart Failure.
    Lanser L; Poelzl G; Messner M; Ungericht M; Zaruba MM; Hirsch J; Hechenberger S; Obersteiner S; Koller B; Ulmer H; Weiss G
    J Am Heart Assoc; 2024 May; 13(9):e032540. PubMed ID: 38639356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design.
    Mentz RJ; Ambrosy AP; Ezekowitz JA; Lewis GD; Butler J; Wong YW; De Pasquale CG; Troughton RW; O'Meara E; Rockhold FW; Garg J; Samsky MD; Leloudis D; Dugan M; Mundy LM; Hernandez AF;
    Circ Heart Fail; 2021 May; 14(5):e008100. PubMed ID: 34003690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of transferrin saturation in heart failure patients.
    Campodonico J; Nicoli F; Motta I; Migone De Amicis M; Bonomi A; Cappellini M; Agostoni P
    Eur J Prev Cardiol; 2021 Dec; 28(15):1639-1646. PubMed ID: 33619543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron deficiency in heart failure patients: the French CARENFER prospective study.
    Cohen-Solal A; Philip JL; Picard F; Delarche N; Taldir G; Gzara H; Korichi A; Trochu JN; Cacoub P;
    ESC Heart Fail; 2022 Apr; 9(2):874-884. PubMed ID: 35170249
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.